Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
出版年份 2019 全文链接
标题
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-04-10
DOI
10.3389/fimmu.2019.00725
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic Immune Modulation Against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
- (2018) Chrisann Kyi et al. CLINICAL CANCER RESEARCH
- TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells
- (2018) Mahyar Nouri-Shirazi et al. IMMUNOLOGY LETTERS
- TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy
- (2018) So-Yon Lim et al. Science Translational Medicine
- Towards superior dendritic-cell vaccines for cancer therapy
- (2018) Mansi Saxena et al. Nature Biomedical Engineering
- Barriers for HIV Cure: The Latent Reservoir
- (2018) Sergio Castro-Gonzalez et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity
- (2018) Sreekumar Balan et al. Cell Reports
- Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
- (2017) Angela Tsai et al. JOURNAL OF VIROLOGY
- Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells
- (2017) David Alvarez-Carbonell et al. Retrovirology
- Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system
- (2017) Liang Cheng et al. VACCINE
- The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
- (2017) Carlene Petes et al. Frontiers in Immunology
- Modulation of innate immunity in the tumor microenvironment
- (2016) Elena Gonzalez-Gugel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- HIV infection: focus on the innate immune cells
- (2016) Milena S. Espíndola et al. IMMUNOLOGIC RESEARCH
- A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+T Cells
- (2016) Rasmus Offersen et al. JOURNAL OF VIROLOGY
- Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity
- (2016) Stina L. Urban et al. VIROLOGY
- A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
- (2016) R. Brad Jones et al. PLoS Pathogens
- Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques
- (2016) Gerard Zurawski et al. PLoS One
- PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo
- (2016) Meropi Aravantinou et al. PLoS One
- Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection
- (2015) Elizabeth A. Miller et al. AIDS
- Attenuated Listeria monocytogenes Vectors Overcome Suppressive Plasma Factors During HIV Infection to Stimulate Myeloid Dendritic Cells to Promote Adaptive Immunity and Reactivation of Latent Virus
- (2015) Elizabeth A. Miller et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid–poly- l -lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy
- (2015) Elizabeth Miller et al. VACCINE
- Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
- (2014) H. Okada et al. CLINICAL CANCER RESEARCH
- Vaccine adjuvant uses of poly-IC and derivatives
- (2014) Karen AO Martins et al. Expert Review of Vaccines
- A Randomized Open-Label Study of Three- versus Five-Drug Combination Antiretroviral Therapy in Newly HIV-1 Infected Individuals
- (2014) Martin Markowitz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
- (2014) M. V. Dhodapkar et al. Science Translational Medicine
- HIV-1 Latency: An Update of Molecular Mechanisms and Therapeutic Strategies
- (2014) Angela Battistini et al. Viruses-Basel
- Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
- (2014) A. M. Salazar et al. Cancer Immunology Research
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- NOD-Like Receptors: Master Regulators of Inflammation and Cancer
- (2014) Mansi Saxena et al. Frontiers in Immunology
- TLR/NCR/KIR: Which One to Use and When?
- (2014) Simona Sivori et al. Frontiers in Immunology
- CD38 and CD157: A long journey from activation markers to multifunctional molecules
- (2013) Valeria Quarona et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Polyinosinic-Polycytidylic Acid Is the Most Effective TLR Adjuvant for SIV Gag Protein-Induced T Cell Responses In Nonhuman Primates
- (2013) H. Park et al. JOURNAL OF IMMUNOLOGY
- Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
- (2013) Christine Katlama et al. LANCET
- The search for an HIV cure: tackling latent infection
- (2013) Stephen J Kent et al. LANCET INFECTIOUS DISEASES
- Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity
- (2013) Amanda Jacobson et al. PLoS One
- Reactivation of latent HIV-1 in central memory CD4+ T cells through TLR-1/2 stimulation
- (2013) Camille L Novis et al. Retrovirology
- CD56negCD16+ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
- (2013) Jeffrey M Milush et al. Retrovirology
- Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial
- (2013) T. Tsuji et al. Cancer Immunology Research
- Plasma Factors During Chronic HIV-1 Infection Impair IL-12 Secretion by Myeloid Dendritic Cells via a Virus-Independent Pathway
- (2012) Elizabeth A. Miller et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44
- (2012) Davor Frleta et al. JOURNAL OF CLINICAL INVESTIGATION
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection
- (2011) J. Judy Chang et al. AIDS
- DDX1, DDX21, and DHX36 Helicases Form a Complex with the Adaptor Molecule TRIF to Sense dsRNA in Dendritic Cells
- (2011) Zhiqiang Zhang et al. IMMUNITY
- Tenofovir Selectively Regulates Production of Inflammatory Cytokines and Shifts the IL-12/IL-10 Balance in Human Primary Cells
- (2011) Jesper Melchjorsen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
- (2011) Marina Caskey et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
- (2011) B. J. Flynn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation at serine 318 is not required for inhibition of T cell activation by ALX
- (2010) Michael J. Shapiro et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation
- (2010) Panagiotis Vagenas et al. PLoS One
- Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
- (2009) Stephen McCartney et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+Th1 immunity with poly IC as adjuvant
- (2009) M. Paula Longhi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Monocyte‐Derived Dendritic Cells from HIV Type 1–Infected Individuals Show Reduced Ability to Stimulate T Cells and Have Altered Production of Interleukin (IL)–12 and IL‐10
- (2009) Sandrine Buisson et al. JOURNAL OF INFECTIOUS DISEASES
- TLR3: Interferon induction by double-stranded RNA including poly(I:C)☆
- (2008) M MATSUMOTO et al. ADVANCED DRUG DELIVERY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now